Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ashley Frazer-Abel

Concepts (337)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Complement System Proteins
17
2025
316
4.120
 Why?
Complement Activation
14
2025
411
1.420
 Why?
Laboratories
3
2024
109
0.990
 Why?
Complement Factor B
6
2025
106
0.810
 Why?
Immunoassay
2
2021
109
0.700
 Why?
Macular Degeneration
4
2025
191
0.620
 Why?
Clinical Laboratory Techniques
2
2018
96
0.610
 Why?
Laboratories, Hospital
1
2018
13
0.570
 Why?
Anti-Citrullinated Protein Antibodies
4
2026
126
0.550
 Why?
Oligonucleotides, Antisense
3
2025
116
0.540
 Why?
Blood Chemical Analysis
1
2018
109
0.530
 Why?
RNA, Transfer
3
2008
144
0.490
 Why?
Angioedemas, Hereditary
2
2014
4
0.460
 Why?
Kidney Diseases
3
2025
427
0.420
 Why?
RNA
3
2008
940
0.400
 Why?
Antibodies, Monoclonal, Humanized
2
2023
988
0.390
 Why?
Arthritis, Rheumatoid
4
2026
1169
0.380
 Why?
Autoimmune Diseases
4
2022
463
0.380
 Why?
Anticodon
3
2004
24
0.370
 Why?
Nucleic Acid Conformation
4
2008
726
0.370
 Why?
Wet Macular Degeneration
2
2025
58
0.360
 Why?
Angioedema
1
2011
15
0.340
 Why?
Geographic Atrophy
2
2025
97
0.340
 Why?
Complement Inactivating Agents
2
2025
74
0.340
 Why?
Emergency Responders
2
2021
37
0.330
 Why?
Humans
56
2026
144957
0.300
 Why?
Immunologic Tests
2
2021
15
0.300
 Why?
Cyclin-Dependent Kinase 4
3
2006
53
0.300
 Why?
Autoantibodies
3
2021
1504
0.290
 Why?
T-Lymphocytes
3
2009
1982
0.290
 Why?
Complement Pathway, Alternative
3
2025
122
0.290
 Why?
Diabetic Retinopathy
2
2022
208
0.280
 Why?
Immunoglobulins, Intravenous
2
2019
126
0.280
 Why?
Specimen Handling
2
2022
186
0.280
 Why?
Autoimmunity
2
2025
927
0.250
 Why?
Smoking
3
2019
1472
0.250
 Why?
Tars
1
2006
5
0.240
 Why?
Complement Factor H
2
2019
80
0.240
 Why?
Nicotine
2
2009
332
0.230
 Why?
Glomerulonephritis, IGA
1
2025
12
0.230
 Why?
Cyclin-Dependent Kinase 6
1
2006
49
0.230
 Why?
Hydroxychloroquine
1
2026
63
0.230
 Why?
Inflammation
5
2026
2880
0.220
 Why?
Choroid
1
2025
80
0.220
 Why?
Thionucleotides
1
2025
35
0.220
 Why?
Complement C3a
3
2019
40
0.220
 Why?
RNA, Transfer, Ser
2
2008
4
0.220
 Why?
Cell Cycle
2
2006
597
0.220
 Why?
B-Cell Activating Factor
1
2024
21
0.220
 Why?
Complement Factor D
1
2024
28
0.210
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2024
76
0.200
 Why?
Nuclear Proteins
3
2004
749
0.200
 Why?
Complement C3
3
2025
191
0.200
 Why?
Atypical Hemolytic Uremic Syndrome
1
2023
21
0.200
 Why?
Scleroderma, Systemic
1
2024
123
0.200
 Why?
Biomarkers
6
2026
4275
0.200
 Why?
Quality Control
2
2021
163
0.200
 Why?
Disease Susceptibility
4
2020
348
0.200
 Why?
Vitreous Body
2
2022
117
0.200
 Why?
Quantitative Trait Loci
1
2025
374
0.190
 Why?
Biosimilar Pharmaceuticals
1
2023
28
0.190
 Why?
Antirheumatic Agents
1
2026
304
0.190
 Why?
Trichloroethylene
1
2022
8
0.180
 Why?
Protein Aggregates
2
2019
86
0.180
 Why?
Muscular Dystrophy, Facioscapulohumeral
1
2022
29
0.180
 Why?
Neuromyelitis Optica
1
2023
138
0.180
 Why?
Complement Inactivator Proteins
1
2021
39
0.170
 Why?
Cross Reactions
1
2021
130
0.170
 Why?
Extracellular Traps
1
2021
57
0.170
 Why?
Reference Standards
1
2021
178
0.170
 Why?
Europe
2
2020
412
0.170
 Why?
Retinal Drusen
1
2021
31
0.170
 Why?
Magnesium
4
2008
155
0.170
 Why?
Immunologic Factors
2
2022
255
0.160
 Why?
Health Status
1
2026
836
0.160
 Why?
DNA-Binding Proteins
3
2004
1500
0.160
 Why?
Transcription Factors
4
2004
1742
0.150
 Why?
Sputum
1
2021
308
0.150
 Why?
Alzheimer Disease
1
2026
622
0.150
 Why?
Polyvinyl Chloride
1
2019
12
0.150
 Why?
Diethylhexyl Phthalate
1
2019
15
0.150
 Why?
Complement Membrane Attack Complex
1
2019
38
0.150
 Why?
Male
23
2026
72406
0.150
 Why?
Islets of Langerhans
1
2025
833
0.150
 Why?
Female
24
2026
78376
0.140
 Why?
Rheumatoid Factor
1
2019
175
0.140
 Why?
Insulin-Secreting Cells
1
2023
388
0.140
 Why?
Biological Products
1
2022
252
0.140
 Why?
Choroidal Neovascularization
1
2019
57
0.140
 Why?
Mass Spectrometry
1
2021
750
0.140
 Why?
Mitochondria, Heart
1
1999
102
0.140
 Why?
Occupational Exposure
1
2022
354
0.140
 Why?
Aged
12
2026
25947
0.130
 Why?
Tomography, Optical Coherence
3
2025
271
0.130
 Why?
Diabetes Mellitus, Type 1
2
2025
3890
0.130
 Why?
Middle Aged
14
2026
35928
0.130
 Why?
Aged, 80 and over
6
2026
8279
0.120
 Why?
Complement C3 Nephritic Factor
1
2016
1
0.120
 Why?
Complement C5
1
2016
33
0.120
 Why?
Rheumatic Diseases
1
2017
97
0.120
 Why?
Riboflavin
1
2016
15
0.120
 Why?
Virus Inactivation
1
2016
13
0.120
 Why?
Polymorphism, Single Nucleotide
2
2025
2147
0.120
 Why?
Blood
1
2016
109
0.110
 Why?
Base Sequence
4
2008
2191
0.110
 Why?
Glomerulosclerosis, Focal Segmental
1
2015
43
0.110
 Why?
Hemorrhagic Fever, Ebola
1
2016
81
0.110
 Why?
RNA, Fungal
3
2008
73
0.110
 Why?
Ebolavirus
1
2016
89
0.110
 Why?
Aging
1
2026
1966
0.110
 Why?
Critical Illness
1
2021
892
0.110
 Why?
Complement C1 Inhibitor Protein
1
2014
11
0.110
 Why?
RNA, Transfer, Phe
2
2008
9
0.110
 Why?
Animals
11
2022
38109
0.110
 Why?
Oligoribonucleotides
1
2014
52
0.110
 Why?
Disinfection
1
2016
129
0.110
 Why?
Proto-Oncogene Proteins
3
2004
623
0.100
 Why?
Birefringence
3
2004
7
0.100
 Why?
Electrophoresis, Polyacrylamide Gel
2
2008
331
0.100
 Why?
Adult
12
2026
40506
0.100
 Why?
Double-Blind Method
3
2026
2029
0.100
 Why?
Acute Kidney Injury
1
2021
866
0.100
 Why?
Disease Progression
4
2025
2852
0.100
 Why?
Diabetes Mellitus
1
2022
1098
0.100
 Why?
Ultraviolet Rays
1
2016
388
0.100
 Why?
Nanoparticles
1
2019
520
0.100
 Why?
Antibodies, Viral
3
2022
672
0.090
 Why?
Pyrrolidinones
1
2012
29
0.090
 Why?
Risk Factors
5
2026
10792
0.090
 Why?
Comprehension
1
2014
180
0.090
 Why?
Molecular Sequence Data
5
2014
2931
0.090
 Why?
Cyclin-Dependent Kinases
2
2004
123
0.090
 Why?
Complement C1 Inactivator Proteins
1
2011
6
0.090
 Why?
Cattle
2
2008
1000
0.090
 Why?
Complement C4
1
2011
26
0.090
 Why?
Seroepidemiologic Studies
2
2021
172
0.080
 Why?
Case-Control Studies
4
2020
3608
0.080
 Why?
Oligonucleotides
2
2014
151
0.070
 Why?
Inflammation Mediators
1
2012
509
0.070
 Why?
Complement C5a
2
2019
54
0.070
 Why?
Mutation
2
2020
4099
0.070
 Why?
Drug Packaging
2
2019
41
0.070
 Why?
Nicotinic Agonists
1
2009
137
0.070
 Why?
Sequence Deletion
1
2008
193
0.070
 Why?
Particle Size
2
2019
411
0.070
 Why?
Phenotype
3
2022
3164
0.070
 Why?
Mycobacterium Infections, Nontuberculous
1
2012
366
0.070
 Why?
Cells, Cultured
2
2006
4155
0.070
 Why?
Diagnosis, Differential
1
2011
1495
0.060
 Why?
Immunoglobulin G
2
2022
893
0.060
 Why?
NFATC Transcription Factors
2
2004
93
0.060
 Why?
Lymphocyte Activation
2
2012
1126
0.060
 Why?
Resting Phase, Cell Cycle
1
2006
16
0.060
 Why?
Chemokine CXCL5
1
2026
19
0.060
 Why?
Cell Survival
1
2009
1098
0.060
 Why?
Chemokine CXCL9
1
2026
38
0.060
 Why?
Enzyme Induction
1
2006
88
0.060
 Why?
G1 Phase
1
2006
66
0.060
 Why?
Kidney
2
2025
1496
0.060
 Why?
Proteinuria
1
2025
102
0.060
 Why?
Macaca fascicularis
2
2016
71
0.060
 Why?
Phenols
1
2006
114
0.060
 Why?
Temperature
1
2008
679
0.060
 Why?
Enzyme-Linked Immunosorbent Assay
2
2019
851
0.050
 Why?
Chromosome Mapping
1
2025
510
0.050
 Why?
Peptides, Cyclic
1
2026
275
0.050
 Why?
Hemangiosarcoma
1
2004
23
0.050
 Why?
RNA Processing, Post-Transcriptional
1
2004
92
0.050
 Why?
Young Adult
4
2025
14126
0.050
 Why?
Amyloid beta-Peptides
1
2026
241
0.050
 Why?
Follow-Up Studies
2
2025
5417
0.050
 Why?
Plasmids
1
2004
379
0.050
 Why?
Dog Diseases
1
2004
70
0.050
 Why?
Rare Diseases
1
2023
113
0.050
 Why?
Interferon-gamma
1
2026
784
0.050
 Why?
Complement Factor I
1
2022
12
0.050
 Why?
Neovascularization, Pathologic
1
2004
286
0.050
 Why?
Cross-Sectional Studies
2
2025
5872
0.050
 Why?
Aqueous Humor
1
2022
38
0.050
 Why?
Antibodies, Antinuclear
1
2022
62
0.050
 Why?
Glomerular Filtration Rate
1
2025
760
0.040
 Why?
Interleukin-6
1
2026
780
0.040
 Why?
Time Factors
2
2025
7183
0.040
 Why?
World Health Organization
1
2022
105
0.040
 Why?
Cytokines
2
2012
2065
0.040
 Why?
Albumins
1
2022
118
0.040
 Why?
Adolescent
5
2025
22453
0.040
 Why?
Fibrinogen
1
2022
177
0.040
 Why?
Gene Expression Regulation
2
2002
2609
0.040
 Why?
Apoptosis
1
2009
2430
0.040
 Why?
Microspheres
1
2021
142
0.040
 Why?
Pancreas
1
2023
342
0.040
 Why?
Colorado
2
2021
4564
0.040
 Why?
Spike Glycoprotein, Coronavirus
1
2022
130
0.040
 Why?
Cardiac Catheterization
1
2024
560
0.040
 Why?
United States
1
2018
15988
0.040
 Why?
Vascular Endothelial Growth Factor A
2
2019
557
0.040
 Why?
Immunoglobulin M
1
2022
284
0.040
 Why?
RNA, Messenger
3
2004
2832
0.040
 Why?
RNA, Bacterial
1
2001
189
0.040
 Why?
Vitrectomy
1
2020
73
0.040
 Why?
Predictive Value of Tests
1
2025
2118
0.040
 Why?
Child
4
2025
22657
0.040
 Why?
Complement C4a
1
2019
9
0.040
 Why?
Freezing
1
2019
86
0.040
 Why?
Plasticizers
1
2019
20
0.040
 Why?
Syringes
1
2019
49
0.040
 Why?
Drug Contamination
1
2019
52
0.040
 Why?
Gas Chromatography-Mass Spectrometry
1
2019
131
0.040
 Why?
South Carolina
1
2019
48
0.040
 Why?
Cations, Divalent
1
1999
47
0.040
 Why?
Drug Compounding
1
2019
107
0.040
 Why?
Drug Stability
1
2019
164
0.040
 Why?
Rheology
1
2019
94
0.040
 Why?
Yeasts
1
1999
52
0.040
 Why?
Protein Stability
1
2019
178
0.040
 Why?
Cell Proliferation
1
2006
2499
0.030
 Why?
Calcium
1
2004
1184
0.030
 Why?
Fluorescein Angiography
1
2019
189
0.030
 Why?
Surface Properties
1
2019
410
0.030
 Why?
Pituitary Gland, Anterior
1
1997
37
0.030
 Why?
Complement Pathway, Classical
1
2017
19
0.030
 Why?
Thrombotic Microangiopathies
1
2017
19
0.030
 Why?
Prolactin
1
1997
89
0.030
 Why?
Complement Pathway, Mannose-Binding Lectin
1
2017
23
0.030
 Why?
Body Mass Index
2
2019
2438
0.030
 Why?
Fibroblast Growth Factor 2
1
1997
93
0.030
 Why?
Stress, Mechanical
1
2019
494
0.030
 Why?
Anti-Inflammatory Agents
1
2021
475
0.030
 Why?
Promoter Regions, Genetic
2
2002
1258
0.030
 Why?
Mice
3
2022
18365
0.030
 Why?
Biomarkers, Tumor
1
2024
1322
0.030
 Why?
Epitopes
1
2019
485
0.030
 Why?
HIV Infections
1
2012
3154
0.030
 Why?
Genetic Testing
1
2020
482
0.030
 Why?
Genetic Predisposition to Disease
1
2025
2365
0.030
 Why?
Jurkat Cells
2
2009
114
0.030
 Why?
Escherichia coli
1
2001
855
0.030
 Why?
Odds Ratio
1
2019
1077
0.030
 Why?
Fibroblast Growth Factors
1
1997
188
0.030
 Why?
Motivation
1
2021
610
0.030
 Why?
Disease Management
1
2020
647
0.030
 Why?
Severity of Illness Index
1
2024
2925
0.030
 Why?
Vero Cells
1
2016
84
0.030
 Why?
Complement C5b
1
2015
5
0.030
 Why?
Child, Preschool
2
2025
11799
0.030
 Why?
Societies, Medical
1
2020
887
0.030
 Why?
Intensive Care Units
1
2021
916
0.030
 Why?
Lupus Erythematosus, Systemic
1
2017
239
0.030
 Why?
Patient Education as Topic
1
2020
780
0.030
 Why?
Molecular Targeted Therapy
1
2017
434
0.030
 Why?
Longitudinal Studies
1
2022
2947
0.030
 Why?
Amino Acid Sequence
2
2014
2157
0.030
 Why?
Quality Assurance, Health Care
1
2016
340
0.030
 Why?
Retrospective Studies
2
2025
17101
0.030
 Why?
Gene Expression
1
2019
1490
0.030
 Why?
Logistic Models
1
2019
2119
0.020
 Why?
Signal Transduction
3
2009
5233
0.020
 Why?
RNA Polymerase II
1
1997
351
0.020
 Why?
Binding Sites
3
2002
1331
0.020
 Why?
Saccharomyces cerevisiae Proteins
1
1997
419
0.020
 Why?
Clinical Decision-Making
1
2016
359
0.020
 Why?
gag Gene Products, Human Immunodeficiency Virus
1
2012
10
0.020
 Why?
Hypertension, Pulmonary
1
2024
1980
0.020
 Why?
CD4-CD8 Ratio
1
2012
23
0.020
 Why?
nef Gene Products, Human Immunodeficiency Virus
1
2012
19
0.020
 Why?
Raltegravir Potassium
1
2012
18
0.020
 Why?
Funnel Chest
1
2012
29
0.020
 Why?
Chemokine CCL5
1
2012
41
0.020
 Why?
Adipokines
1
2012
57
0.020
 Why?
Insulin
1
2023
2507
0.020
 Why?
Practice Guidelines as Topic
1
2020
1563
0.020
 Why?
Muscle, Skeletal
1
2022
1796
0.020
 Why?
Cell Division
2
2004
766
0.020
 Why?
Age Factors
1
2019
3335
0.020
 Why?
Antiretroviral Therapy, Highly Active
1
2012
278
0.020
 Why?
Treatment Outcome
1
2025
11695
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
2032
0.020
 Why?
Viral Load
1
2012
526
0.020
 Why?
Immunologic Memory
1
2012
366
0.020
 Why?
Leukemia, T-Cell
1
2009
5
0.020
 Why?
Scoliosis
1
2012
224
0.020
 Why?
Prospective Studies
1
2021
7997
0.020
 Why?
Algorithms
1
2016
1839
0.020
 Why?
Adipose Tissue
1
2012
653
0.020
 Why?
Transfection
2
2002
940
0.020
 Why?
Receptors, Nicotinic
1
2009
323
0.020
 Why?
Pilot Projects
1
2012
1890
0.020
 Why?
HIV-1
1
2012
896
0.010
 Why?
CD8-Positive T-Lymphocytes
1
2012
917
0.010
 Why?
CD4-Positive T-Lymphocytes
1
2012
1129
0.010
 Why?
Ploidies
1
2004
20
0.010
 Why?
DNA, Neoplasm
1
2004
164
0.010
 Why?
Precipitin Tests
1
2002
93
0.010
 Why?
Protein Binding
2
2001
2276
0.010
 Why?
Dogs
1
2004
438
0.010
 Why?
Cell Adhesion
1
2004
455
0.010
 Why?
Luciferases
1
2002
152
0.010
 Why?
Genes, Reporter
1
2002
276
0.010
 Why?
Cloning, Molecular
1
2002
541
0.010
 Why?
Cyclosporine
1
2002
265
0.010
 Why?
Tacrolimus
1
2002
196
0.010
 Why?
Exons
1
2002
358
0.010
 Why?
Base Pairing
1
2001
65
0.010
 Why?
Histone Deacetylases
1
2002
210
0.010
 Why?
Antigens, CD
1
2004
555
0.010
 Why?
Lymphocytes
1
2002
382
0.010
 Why?
Transcriptional Activation
1
2002
383
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2002
983
0.010
 Why?
RNA Stability
1
2001
119
0.010
 Why?
Models, Genetic
1
2002
536
0.010
 Why?
Ribosomes
1
2001
191
0.010
 Why?
Cell Movement
1
2004
965
0.010
 Why?
Chromatin
1
2002
561
0.010
 Why?
Phosphorylation
1
2002
1733
0.010
 Why?
Transcription Factor Pit-1
1
1997
26
0.010
 Why?
Fibroblast Growth Factor 4
1
1997
19
0.010
 Why?
Proto-Oncogene Proteins c-raf
1
1997
45
0.010
 Why?
Proto-Oncogene Protein c-ets-1
1
1997
26
0.010
 Why?
Proto-Oncogene Proteins c-ets
1
1997
56
0.010
 Why?
Endothelium, Vascular
1
2004
965
0.010
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1997
168
0.010
 Why?
Mice, Transgenic
1
2002
2185
0.010
 Why?
Genes, Fungal
1
1997
55
0.010
 Why?
Coenzymes
1
1997
19
0.010
 Why?
Catalysis
1
1997
322
0.010
 Why?
Proto-Oncogene Proteins p21(ras)
1
1997
253
0.010
 Why?
Gene Expression Regulation, Fungal
1
1997
78
0.010
 Why?
Models, Biological
1
2004
1822
0.010
 Why?
Fungal Proteins
1
1997
145
0.010
 Why?
Mediator Complex
1
1997
61
0.010
 Why?
Cell Line, Tumor
1
2004
3550
0.010
 Why?
Tumor Cells, Cultured
1
1997
919
0.010
 Why?
Models, Molecular
1
2001
1619
0.010
 Why?
Protein-Tyrosine Kinases
1
1997
433
0.010
 Why?
Homeodomain Proteins
1
1997
524
0.010
 Why?
Rats
1
1997
5614
0.000
 Why?
Frazer-Abel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (337) concept(s)
_
Co-Authors Expand Description
See all (63) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)